QPRC Quest Patent Research
We are an intellectual property asset management company. Our principal operations include the development, acquisition, licensing and enforcement of intellectual property rights that are either owned or controlled by us or one of our wholly-owned subsidiaries. We currently own, control or manage eleven intellectual property portfolios, which principally consist of patent rights. Our eleven intellectual property portfolios include the portfolios which we acquired from Intellectual Ventures Assets 16, LLC (“Intellectual Ventures”) and seven of its affiliates. As part of our intellectual property asset management activities and in the ordinary course of our business, it has been necessary for us or the intellectual property owner who we represent to initiate, and it is likely to continue to be necessary to initiate, patent infringement lawsuits and engage in patent infringement litigation. We anticipate that our primary source of revenue will come from the grant of licenses to use our intellectual property including licenses granted as part of the settlement of patent infringement lawsuits.
Company profile
Ticker
QPRC
Exchange
Website
CEO
Jon Charles Scahill
Employees
Location
Fiscal year end
Industry (SIC)
Former names
PHASE OUT OF AMERICA INC, QUEST PRODUCTS CORP
SEC CIK
Corporate docs
QPRC stock data
()
Calendar
1 Apr 21
13 Apr 21
31 Dec 21
Financial summary
Quarter (USD) |
Sep 20 | Jun 20 | Mar 20 | Sep 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) |
Dec 19 | Dec 18 | Dec 17 | Dec 16 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Financial data from company earnings reports.
Cash burn rate (estimated) | Burn method: Change in cash | Burn method: Operating income/loss | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 91.88K | 91.88K | 91.88K | 91.88K | 91.88K | 91.88K |
Cash burn (monthly) | 256.83K | 27.05K | (positive/no burn) | 91.73K | 256.83K | 34.51K |
Cash used (since last report) | 1.66M | 175.12K | n/a | 593.83K | 1.66M | 223.43K |
Cash remaining | -1.57M | -83.24K | n/a | -501.95K | -1.57M | -131.55K |
Runway (months of cash) | -6.1 | -3.1 | n/a | -5.5 | -6.1 | -3.8 |
Financial report summary
?Competition
AIkido Pharma • Document Security Systems • Parkervision • Acacia Research • Virnetx Holding • Netlist • Finjan • Marathon DigitalManagement Discussion
- Revenues for the three months ended September 30, 2020 were approximately $3,405,000, an increase of approximately $2,765,000, or 432%, from the comparable period of 2019, which were approximately $640,000. Revenues for the nine months ended September 30, 2020 were approximately $5,488,000, an increase of approximately $3,486,000, or 174%, from the comparable period of 2019, which was approximately $2,002,000. We generated revenue from patent fees of approximately $3,405,000 and $5,488,000 for the three and nine months ended September 30, 2020, respectively, from licenses to the CXT, M-RED and power management portfolios. Our revenue, in the near future if not longer, is likely to be affected by factors relating to the COVID-19 pandemic as described under “Overview”. We generated revenue from patent fees of approximately $640,000 and approximately $2,002,000 for the three and nine months ended September 30, 2019, respectively, from settlements in the CXT portfolio actions, anchor structure portfolio actions, power management/bus controller portfolio actions and CMOS portfolio actions. The total settlement recovery is included in revenue and the associated costs are deducted as cost of revenue. As discussed above, the timing and amount of our revenue is dependent upon the results of litigation seeking to enforce our intellectual property rights, and we cannot predict when or whether we will have a recovery and how much of the recovery will be received by us after payments to legal counsel, to our funding sources, or to inventors/former patent owners who have an interest in our share of the recovery from certain patent portfolios after deducting payments due to counsel and the litigation funding source. Since our revenue is dependent upon our success in litigation, the timing of revenue is dependent upon the timing of litigation and our success in the litigation as well as the ability of defendants to make any agreed-upon payments. As a result, we expect that our revenue will continue to be subject to significant changes from quarter to quarter.
Content analysis
?
Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
agent, agreeable, alleged, assertion, back, behalf, earlier, escrow, extended, forebear, modification, mutually, noteholder, partner, percent, restructure, restructuring, satisfaction, standstill, successor, thereof, unexercised
Removed:
Academy, Apple, Fossil, Madden, Neiman, suit, Tailored
Financial reports
NT 10-K
Notice of late annual filing
1 Apr 21
10-Q
2020 Q3
Quarterly report
15 Nov 20
10-Q
2020 Q2
Quarterly report
14 Aug 20
10-Q
2020 Q1
Quarterly report
13 May 20
10-K
2019 FY
Annual report
27 Mar 20
10-Q
2019 Q3
Quarterly report
14 Nov 19
10-Q
2019 Q2
Quarterly report
13 Aug 19
10-Q
2019 Q1
Quarterly report
15 May 19
10-K
2018 FY
Annual report
16 Apr 19
NT 10-K
Notice of late annual filing
1 Apr 19
Current reports
8-K
Regulation FD Disclosure
2 Mar 21
8-K
Quest Patent Research Enters into $27 Million Capital Facility for Acquisition Growth Capital
25 Feb 21
8-K
Prepaid Forward Purchase Agreement
24 Feb 21
8-K
Entry into a Material Definitive Agreement
6 Nov 20
8-K
Entry into a Material Definitive Agreement
29 Oct 20
8-K
Entry into a Material Definitive Agreement
2 Oct 20
8-K
Other Events
31 Aug 20
8-K
Amendments to Articles of Incorporation or Bylaws
15 Jun 17
8-K
Amendments to Articles of Incorporation or Bylaws
24 Jan 16
8-K
Entry into a Material Definitive Agreement
27 Oct 15
Registration and prospectus
POS AM
Prospectus update (post-effective amendment)
9 Jul 19
POS AM
Prospectus update (post-effective amendment)
4 May 18
POS AM
Prospectus update (post-effective amendment)
29 Jun 17
424B3
Prospectus supplement
10 Feb 16
S-1/A
IPO registration (amended)
7 Feb 16
S-1/A
IPO registration (amended)
2 Feb 16
S-1
IPO registration
13 Dec 15
S-8
Registration of securities for employees
20 Oct 96
Proxies
No filings
Other
EFFECT
Notice of effectiveness
16 Jul 19
EFFECT
Notice of effectiveness
11 May 18
EFFECT
Notice of effectiveness
5 Jul 17
EFFECT
Notice of effectiveness
10 Feb 16
CORRESP
Correspondence with SEC
8 Feb 16
CORRESP
Correspondence with SEC
7 Feb 16
CORRESP
Correspondence with SEC
7 Feb 16
UPLOAD
Letter from SEC
4 Feb 16
CORRESP
Correspondence with SEC
2 Feb 16
UPLOAD
Letter from SEC
4 Jan 16
Reddit threads
Daily Plays - March 04, 2021
4 Mar 21
My stock picks for March 2021 to buy today, NOW
1 Mar 21
THE LOUNGE: thoughts, noob stuff, low effort, brokers, zero DD, non pennies - February 25, 2021
24 Feb 21
A List of Profitable US Based OTC Companies Trading under $0.10
22 Feb 21
ACHI ready for take off
14 Feb 21
How I do due diligence
11 Feb 21
Watch out for bad actors out there. There are people that do exactly this
11 Feb 21